$LUNG Income Statement | Understand Stock

$LUNG

$1.98 +$0.03 (1.54%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Cost of goods sold
Gross profit
Operating expenses
Research and development
Selling, general and administrative
Total operating expenses
Loss from operations
Interest income
Interest expense
Other income, net
Net loss before tax
Income tax expense
Net loss
Other comprehensive income (loss)
Currency translation adjustment
Change in unrealized losses on marketable securities
Total other comprehensive income (loss)
Comprehensive loss
Net loss per share attributable to common stockholders, basic (in dollars per share)
Net loss per share attributable to common stockholders, diluted (in dollars per share)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in shares)
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted (in shares)

Comments